Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

Patsopoulos NA;Esposito F;Reischl J;Lehr S;Bauer D;Heubach J;Sandbrink R;Pohl C;Edan G;Kappos L;Miller D;Montalbán X;Polman CH;Freedman MS;Hartung HP;Arnason BGW;COMI , GIANCARLO;Cook S;FILIPPI , MASSIMO;Goodin DS;Jeffery D;O'Connor P;Ebers GC;Langdon D;Reder AT;Traboulsee A;Zipp F;Schimrigk J;Hillert J;Bahlo M;Booth DR;BroadleyS;Brown MA;Browning BL;Browning SR;Butzkueven H;Carroll WM;Chapman C;Foote SJ;Griffiths L;Kermode AG;Kilpatrick TJ;Lechner Scott J;Marriott M;Mason D;Moscato P;Heard RN;Pender MP;Perreau VM;Perera D;Rubio JP;Scott RJ;Slee M;Stankovich J;Stewart GJ;Taylor BV;Tubridy N;Willoughby E;Wiley J;Matthews P;Boneschi F;Compston A;Haines J;Hauser SL;McCauley J;Ivinson A;Oksenberg JR;Pericak Vance M;Sawcer SJ;De Jager PL;Hafler DA;de Bakker PIW;the BSP MS Genetics working group;the steering committees of studies evaluating IFNb 1b;a. CCR1 antagonist;ANZgene Consortium;GeneMSA;International Multiple Sclerosis Genetics Consortium

2011-01-01